Yan Liang

机构：Gilead Sciences (United States), Inner Mongolia Medical University · ORCID：0000-0002-6972-2541

发表论文 72 篇 · 总被引 804 次 · h-index 16

代表论文

• Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages (2024 · Acta Pharmacologica Sinica · 被引 85)
• Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer (2025 · eLife · 被引 8)
• Theaflavin suppresses necroptosis by attenuating RIPK1-RIPK3-MLKL signaling and mitigates cisplatin-induced kidney injury in mice (2025 · International Immunopharmacology · 被引 7)
• Scutellarin inhibits ferroptosis by promoting cellular antioxidant capacity through regulating Nrf2 signaling (2025 · Acta Biochimica et Biophysica Sinica · 被引 6)
• Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study (2024 · Inflammatory Bowel Diseases · 被引 4)
• Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Recombinant Neorudin, a New Anticoagulant Drug in Patients With Acute Coronary Syndrome (2024 · Clinical Pharmacology in Drug Development · 被引 3)